NCI Cervical Cancer ‘Last Mile’ Initiative

• Last Mile Initiative

  • Purpose and Rationale
  • Key Activities
  • Information for Researchers

• The SHIP Trial

  • About the Study
  • About the Network
  • Questions and Answers

Latest News and Information

• 
  FDA Approves HPV Tests That Allow for Self-Collection in a Health Care Setting

  On May 14, the Food and Drug Administration (FDA) expanded the approvals of two tests that detect cancer-causing types of human papillomavirus (HPV) in the cervix. Both tests are used as part of screening for cervical cancer.

• 
  NCI Launches Network to Study Self-Collection for HPV Testing to Prevent Cervical Cancer

  ‘Last Mile’ Initiative Will Test Alternative Approach to Screening Through the SHIP Trial Network

• 
  Cancer Healthcast: NCI ‘Last Mile’ Initiative Innovates Self-Sampling for HPV Screening

  New self-sampling technologies screening for HPV could help increase access and reduce cervical cancer among underserved and high-burden populations.